Instil Bio (TIL) Earnings Date & Reports

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer... Show more

Industry: #Precious Metals

Get AI intraday signals

A.I. Advisor

published Earnings

TIL is expected to report earnings to fall 32.26% to -41 cents per share on August 07

Q2'26

Est.

$-0.42

Q1'26

Beat

by $3.38

Q4'25

Beat

by $0.51

Q3'25

Beat

by $1.38

Q2'25

Missed

by $0.23

The last earnings report on May 15 showed earnings per share of -62 cents, beating the estimate of -400 cents. With 8.07K shares outstanding, the current market capitalization sits at 53.78M.

View a ticker or compare two or three

Compare

Penny Stock - Smart AI Trend Trader 60min, (FA)Penny Stock - Smart AI Trend Trader 60min, (FA)

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TIL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement